Cargando…
The lasting influence of LSD1 in the blood
An enzyme called LSD1 that controls the development of blood cells by manipulating gene expression in progenitor cells could be a therapeutic target for leukemia.
Autores principales: | Dent, Sharon YR, Chandra, Joya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687340/ https://www.ncbi.nlm.nih.gov/pubmed/23795303 http://dx.doi.org/10.7554/eLife.00963 |
Ejemplares similares
-
Histone demethylase Lsd1 represses hematopoietic stem and progenitor cell signatures during blood cell maturation
por: Kerenyi, Marc A, et al.
Publicado: (2013) -
Maternal LSD1/KDM1A is an essential regulator of chromatin and transcription landscapes during zygotic genome activation
por: Ancelin, Katia, et al.
Publicado: (2016) -
Maternally provided LSD1/KDM1A enables the maternal-to-zygotic transition and prevents defects that manifest postnatally
por: Wasson, Jadiel A, et al.
Publicado: (2016) -
Radial glia regulate vascular patterning around the developing spinal cord
por: Matsuoka, Ryota L, et al.
Publicado: (2016) -
Reciprocal analyses in zebrafish and medaka reveal that harnessing the immune response promotes cardiac regeneration
por: Lai, Shih-Lei, et al.
Publicado: (2017)